Search Results

Filter
  • 1-10 of  50,263 results for ""Ustekinumab""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS).

  • Authors : Baumgart DC; Medizinische Klinik m.S. Hepatologie und Gastroenterologie, Charité-Universitätsmedizin Berlin, Berlin, Germany. .; Stallmach A

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Crohn Disease*/Crohn Disease*/Crohn Disease*/pathology ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 Sep 03; Vol. 14 (1), pp. 20502. Date of Electronic Publication: 2024 Sep 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis.

  • Authors : Feldman SR; Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina. Electronic address: .; Narbutt J

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use ; Ustekinumab*/Ustekinumab*/Ustekinumab*/administration & dosage

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 440-447. Date of Electronic Publication: 2024 Apr 27.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn's Disease.

  • Authors : Moskow J; Engineering Medicine, Texas A&M Health Science Center, 1020 Holcombe Blvd, Houston, TX, 77030, USA.; Thurston T

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/surgery ; Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use

  • Source: Digestive diseases and sciences [Dig Dis Sci] 2024 Aug; Vol. 69 (8), pp. 2944-2954. Date of Electronic Publication: 2024 May 24.Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long-term extension results.

Subjects: Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use ; Ustekinumab*/Ustekinumab*/Ustekinumab*/administration & dosage ; Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapyPediatric Crohn's disease

  • Source: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Aug; Vol. 79 (2), pp. 315-324. Date of Electronic Publication: 2024 May 27.Publisher: Wiley Country of Publication: United States NLM ID: 8211545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4801

Record details

×
Academic Journal

Long-term effectiveness and persistence rate of ustekinumab dose intensification in a South East Asian inflammatory bowel disease center.

  • Authors : Lim CT; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.; Tay SW

Subjects: Ustekinumab*/Ustekinumab*/Ustekinumab*/administration & dosage ; Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Aug; Vol. 39 (8), pp. 1544-1553. Date of Electronic Publication: 2024 Apr 28.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use; Humans Pediatric Crohn's disease

  • Source: European journal of pediatrics [Eur J Pediatr] 2024 Aug; Vol. 183 (8), pp. 3253-3262. Date of Electronic Publication: 2024 May 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.

  • Authors : Ren H; Department of Gastroenterology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan 430060, Hubei Province, China.; Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Ustekinumab*/Ustekinumab*/Ustekinumab*/administration & dosage ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use

  • Source: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Aug 01; Vol. 30 (8), pp. 1295-1302.Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Review

Morphea in patients with psoriasis treated with ustekinumab: a scoping review.

  • Authors : Metko D; Michael G. DeGroote School of Medicine, McMaster University, 90 Main St W, Hamilton, ON, L8P 1H6, Canada. .; Mehta S

Subjects: Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use ; Ustekinumab*/Ustekinumab*/Ustekinumab*/adverse effects ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy

  • Source: Archives of dermatological research [Arch Dermatol Res] 2024 Jul 27; Vol. 316 (8), pp. 492. Date of Electronic Publication: 2024 Jul 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

×
Academic Journal

AVT04: An Ustekinumab Biosimilar.

  • Authors : Blair HA; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .

Subjects: Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use ; Ustekinumab*/Ustekinumab*/Ustekinumab*/pharmacokinetics ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/therapeutic use

  • Source: Clinical drug investigation [Clin Drug Investig] 2024 Jul; Vol. 44 (7), pp. 549-552. Date of Electronic Publication: 2024 Jul 04.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Vedolizumab versus ustekinumab in Crohn's disease with prior anti-tumor necrosis factor failure: an updated meta-analysis.

  • Authors : Milioli NJ; Department of Gastroenterology and Gastrointestinal Endoscopy, Pontifical Catholic University of Rio Grande do Sul.; Fernandes MV

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Ustekinumab*/Ustekinumab*/Ustekinumab*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2024 Sep 01; Vol. 36 (9), pp. 1068-1074. Date of Electronic Publication: 2024 Jul 02.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9000874 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  50,263 results for ""Ustekinumab""